Thursday, 01 October 2020


Rafarma explores University and Hospital Joint Venture in Thailand

15 September 2020 | News

The 3-day conference outlined the importance of the South-East Asian markets and the significance of joint research projects being commenced between Rafarma Pharmaceuticals in association with Mahidol University, Yala University, and Siriraj Hospital.

Photo Credit: Freepik

Photo Credit: Freepik

Rafarma Pharmaceuticals, Inc. reports that Mr. Anucha Pehtpeng, Rafarma’s Director of Thai Operations, represented the company along with leading research teams from Mahidol University, Yala University, and Siriraj Hospital at a key conference in Bangkok from  29 to 31st August 2020. The main point of the conference was to discuss future collaboration between Rafarma Pharmaceuticals and the above-mentioned institutions.

Mr. Pehtpeng presented Rafarma’s research on the already-proven effects of cannabis-based anti-depression drugs. Mr. Pehtpeng had also presented the company’s advances in a new generation of anti-aging drugs. The conference concluded with Mr. Pehtpeng outlining the importance of the South-East Asian markets and the significance of joint research projects being commenced between Rafarma Pharmaceuticals and the above-mentioned institutions.

The announcement is under "Forward-Looking Statements".


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account